Table 3.
Age group (years) | Base value | Range | Standard deviation | References |
---|---|---|---|---|
Cost per HZ case, $ | ||||
50–59 | 264 | 211.20, 316.80 | 26.94 | Friesen et al. [12]; Ontario calculationsa |
60–64 | 264 | 211.20, 316.80 | 26.94 | |
65–69 | 301 | 240.80, 361.20 | 30.71 | |
70–79 | 301 | 240.80, 361.20 | 30.71 | |
≥ 80 | 301 | 240.80, 361.20 | 30.71 | |
Cost per PHN case, $ | ||||
50–59 | 921 | 571.02, 1270.98 | 178.56 | Friesen et al. [12]; Ontario calculationsa |
60–64 | 921 | 571.02, 1270.98 | 178.56 | |
65–69 | 1639 | 571.02, 1270.98 | 317.77 | |
70–79 | 1639 | 571.02, 1270.98 | 317.77 | |
≥ 80 | 1639 | 1016.18, 2261.82 | 317.77 | |
Vaccine cost, RZV, $ | ||||
All age groups | 122 | 115.90, 128.10 | – | IMS |
Vaccine cost, ZVL, $ | ||||
All age groups | 176.77 | – | – | IMS |
Vaccine administration, $ | ||||
First dose | 4.50 | 4.50, 9.60 | Ontario calculationsa | |
Second dose | 9.60 | 4.50, 9.60 | ||
Costs due to AEs per vaccinated individual, RZV, $ | ||||
50‒59 | 2.88 | 1.44, 4.32 | 0.734 | Ontario calculationsa |
60‒64 | 2.62 | 1.31, 3.93 | 0.668 | |
65‒69 | 2.89 | 1.45, 4.34 | 0.737 | |
70‒79 | 2.81 | 1.41, 4.22 | 0.716 | |
≥ 80 | 2.81 | 1.41, 4.22 | 0.716 | |
Costs due to AEs per vaccinated individual, ZVL, $ | ||||
50‒59 | 1.70 | 0.85, 2.55 | 0.433 | Ontario calculationa |
60‒64 | 1.70 | 0.85, 2.55 | 0.433 | |
65‒69 | 1.70 | 0.85, 2.55 | 0.433 | |
70‒79 | 1.70 | 0.85, 2.55 | 0.433 | |
≥ 80 | 1.70 | 0.85, 2.55 | 0.433 |
All $ refer to Canadian dollars
AE adverse event, HZ herpes zoster, PHN postherpetic neuralgia, RZV adjuvanted recombinant zoster vaccine, ZVL zoster vaccine live
aDerived from Ontario Ministry of Health and Long-term Care (MOHLTC) fee schedules and Ontario Case Costing Initiative (OCCI)